During the past decade, Vejle Hospital conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 20 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 15 clinical trials were completed. i.e. 34.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vejle Hospital" #1 sponsor was "Vejle Hospital" with 21 trials, followed by "Odense University Hospital" with 9 trials sponsored, "Celgene" with 8 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored and "Genmab" with 7 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vejle Hospital" #1 collaborator was "Odense University Hospital" with 9 trials as a collaborator, "Vejle Hospital" with 9 trials as a collaborator, "AbbVie" with 8 trials as a collaborator, "Sygehus Lillebaelt" with 7 trials as a collaborator and "Aarhus University Hospital" with 6 trials as a collaborator. Other collaborators include 127 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Vejle Hospital" are "Multiple Myeloma" (15 trials), "Breast Cancer" (5 trials), "Cancer" (5 trials), "Postoperative Pain" (5 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Vejle Hospital" in a lesser frequency.

Most popular intervention types in "Vejle Hospital" are "Drug" (84 trials), "Biological" (14 trials), "Other" (13 trials), "Procedure" (9 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (15 trials), "Placebo" (13 trials), "Pomalidomide" (6 trials), "Capecitabine" (5 trials) and "Daratumumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Vejle Hospital" are 119 trials for "All" genders, 9 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Vejle Hospital". 1 are not yet recruiting, 37 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Vejle Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Vejle Hospital, 16 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 27 trials that are defined as “Not Applicable".